Dr. Basil Petrof, Professor of Medicine, has been appointed Director of the Meakins-Christie Laboratories effective May 15, 2017, for a five-year term. As Director, Dr. Petrof will be responsible for the scientific leadership and administration of the Meakins-Christie Laboratories. Dr. Petrof is an accomplished and internationally recognized scientist for his work on respiratory muscle dysfunction and sleep-disordered breathing.
Basil Petrof heads the program for translational research in respiratory diseases at the Research Institute of the McGill University Health Centre (RI-MUHC). His research group recently participated in a clinical trial that proved the efficacy of a new therapy that burns away the muscle tissue in the lungs of asthmatic patients to help open their airways. It is this kind of cutting-edge discovery that Petrof expects will move more rapidly from concept to proven treatment thanks to the new facilities at the RI-MUHC. (February 2015)